Home Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
 

Keywords :   


Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial

2013-02-14 14:00:00| Merck.com - Corporate News

Dateline City:  WHITEHOUSE STATION, N.J. The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities class-action lawsuits. The suits are pending in the U.S. District Court for the District of New Jersey against Merck, Schering-Plough Corporation and certain of their current and former officers and directors. Language:  English Contact HTML:  MerckMedia Contacts:Ron Rogers, 908-423-6449Steve Cragle, 908-423-3461ORInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: related trial enhance securities

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11US cuts interest rates as Trump election raises uncertainty
07.11The Lehigh Short Course Website is Now Open
07.11Carbon Trust Verifies Four BASF Intermediates
07.11Atlantic Tropical Weather Outlook
07.11Eastern North Pacific Tropical Weather Outlook
07.11Labelink acquires International Label & Printing
07.11Pack Expo International sees record numbers in 2024
07.11Ahlstroms Climate Targets Validated by SBTi
More »